Bio-Gene Technology Limited

Bio-Gene Technology Limitedverified

BGT.AX

Price:

$0.026

Market Cap:

$7.93M

Bio-Gene Technology Limited, an agtech development company, engages in developing and commercializing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University for the development of a tissue culture system to support the expansion of tree plantations and scale-up of future Qcide oil production. It also has research collaborations with BASF, Grains Research and Development Corporation, and Queensland Department...[Read more]

Industry

Biotechnology

IPO Date

2017-11-28

Stock Exchange

ASX

Ticker

BGT.AX

The PE Ratio as of December 2025 (TTM) for Bio-Gene Technology Limited (BGT.AX) is -2.60

According to Bio-Gene Technology Limited’s latest financial reports and current stock price. The company's current PE Ratio is -2.60. This represents a change of 38.82% compared to the average of -1.87 of the last 4 quarters.

Bio-Gene Technology Limited (BGT.AX) Historical PE Ratio (quarterly & annually)

How has BGT.AX PE Ratio performed in the past?

The mean historical PE Ratio of Bio-Gene Technology Limited over the last ten years is -14.84. The current -2.60 PE Ratio has changed 1.65% with respect to the historical average. Over the past ten years (40 quarters), BGT.AX's PE Ratio was at its highest in in the December 2024 quarter at -1.47. The PE Ratio was at its lowest in in the December 2014 quarter at -95.60.

Quarterly (TTM)
Annual

Average

-14.84

Median

-6.84

Minimum

-78.27

Maximum

-1.31

Bio-Gene Technology Limited (BGT.AX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Bio-Gene Technology Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 48.73%

Maximum Annual PE Ratio = -1.31

Minimum Annual Increase = -71.39%

Minimum Annual PE Ratio = -78.27

Quarterly (TTM)
Annual
YearPE RatioChange
2025-1.31-66.00%
2024-3.85-9.01%
2023-4.23-38.20%
2022-6.84-29.74%
2021-9.7421.28%
2020-8.0348.73%
2019-5.40-21.17%
2018-6.85-71.39%
2017-23.93-69.43%
2016-78.27-59.06%

Bio-Gene Technology Limited (BGT.AX) Average PE Ratio

How has BGT.AX PE Ratio performed in the past?

The current PE Ratio of Bio-Gene Technology Limited (BGT.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.13

5-year avg

-5.19

10-year avg

-14.84

Bio-Gene Technology Limited (BGT.AX) PE Ratio vs. Peers

How is BGT.AX’s PE Ratio compared to its peers?

Bio-Gene Technology Limited’s PE Ratio is greater than Invex Therapeutics Ltd (-18.99), greater than Vectus Biosystems Limited (-3.30), less than Intelicare Holdings Limited (0), less than Memphasys Limited (-1.61), less than Percheron Therapeutics Limited (-0.48), less than Acrux Limited (-1.08), greater than Biotron Limited (-10.32), less than Chimeric Therapeutics Limited (-0.89), greater than InhaleRx Limited (-3.83), less than Cann Group Limited (-0.21),

Build a custom stock screener for Bio-Gene Technology Limited (BGT.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Gene Technology Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bio-Gene Technology Limited (BGT.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bio-Gene Technology Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Bio-Gene Technology Limited's PE Ratio?

How is the PE Ratio calculated for Bio-Gene Technology Limited (BGT.AX)?

What is the highest PE Ratio for Bio-Gene Technology Limited (BGT.AX)?

What is the 3-year average PE Ratio for Bio-Gene Technology Limited (BGT.AX)?

What is the 5-year average PE Ratio for Bio-Gene Technology Limited (BGT.AX)?

How does the current PE Ratio for Bio-Gene Technology Limited (BGT.AX) compare to its historical average?